Introduction: The aim of the study was to retrospectively identify the metastatic influence factors and predict the prognosis and develop an individualized prognostic prediction model for patients with N3-stage nasopharyngeal carcinoma (NPC). Methods: The study collected 446 NPC patients with N3 stage from the Surveillance, Epidemiology, and End Results database between 2010 and 2015. The patients were classified into subgroups based on the histological types and metastatic status. Multivariable logistic, Cox regression, and Kaplan-Meier method with the log-rank test were performed. The nomogram model was created using the prognostic factors identified from Cox regression analysis. The predictive accuracy was determined based on the concordance index (c-index) and calibration curves. Results: The 5-year overall survival (OS) of the NPC patients with N3 stage was 43.9%, and the prognosis of patients without any distant metastases was largely longer than that with metastases. No difference was observed between different pathological types in the entire cohort. However, patients with non-keratinized squamous cell carcinoma had a better OS than that of the patients with keratinized squamous cell carcinoma in a nonmetastatic subgroup. Using the Cox regression analysis results, the nomogram successfully classified these patients into low- and high-risk subgroups and presented the survival difference. The c-index of the nomogram for predicting the prognosis was satisfactory. Conclusion: This study identified metastatic risk factors and developed a convenient clinical tool for the prognosis of NPC patients. This tool can be used for individualized risk classification and decision-making regarding treatment of NPC patients with N3 stage.

1.
Han
JE
,
Yi
SK
,
Wang
S
,
Erman
A
,
Bearelly
S
,
Sindhu
S
.
Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease
.
Head Neck
.
2019 Dec
41
12
4076
87
.
2.
Cao
SM
,
Simons
MJ
,
Qian
CN
.
The prevalence and prevention of nasopharyngeal carcinoma in China
.
Chin J Cancer
.
2011 Feb
30
2
114
9
.
3.
Zhang
S
,
Zhou
L
,
Huang
X
,
Lin
S
.
A retrospective study of concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy on curative effect for treatment of patients with N3 stage nasopharyngeal carcinoma
.
Cancer Manag Res
.
2018
;
10
:
1705
11
.
4.
Sultan
I
,
Casanova
M
,
Ferrari
A
,
Rihani
R
,
Rodriguez-Galindo
C
.
Differential features of nasopharyngeal carcinoma in children and adults: a SEER study
.
Pediatr Blood Cancer
.
2010 Aug
55
2
279
84
.
5.
Ho
FCH
,
Tham
IWK
,
Earnest
A
,
Lee
KM
,
Lu
JJ
.
Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence
.
BMC Cancer
.
2012 Mar 21
12
98
.
6.
Wang
X
,
Hu
C
,
Ying
H
,
He
X
,
Zhu
G
,
Kong
L
.
Patterns of lymph node metastasis from nasopharyngeal carcinoma based on the 2013 updated consensus guidelines for neck node levels
.
Radiother Oncol
.
2015 Apr
115
1
41
5
.
7.
Chen
YP
,
Tang
LL
,
Yang
Q
,
Poh
SS
,
Hui
EP
,
Chan
ATC
.
Induction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trials
.
Clin Cancer Res
.
2018 Apr 15
24
8
1824
33
.
8.
Zong
J
,
Xu
H
,
Chen
B
,
Guo
Q
,
Xu
Y
,
Chen
C
.
Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma
.
Radiat Oncol
.
2019 Oct 22
14
1
182
.
9.
Xu
Y
,
Chen
X
,
Zhang
M
,
Xiao
Y
,
Zong
J
,
Guo
Q
.
Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study
.
Cancer Med
.
2017 Oct
6
10
2213
21
.
10.
Feng
Y
,
Cao
C
,
Hu
Q
,
Chen
X
.
Prognostic value and staging classification of lymph nodal necrosis in nasopharyngeal carcinoma after intensity-modulated radiotherapy
.
Cancer Res Treat
.
2019 Jul
51
3
1222
30
.
11.
Lin
TY
,
Lan
MY
,
Tsou
HH
,
Ho
CY
,
Twu
CW
,
Liu
YC
.
Survival impacts of different nodal characteristics and T-classification in N3 nasopharyngeal carcinoma patients
.
Oral Oncol
.
2020 Sep
108
104820
.
12.
Guo
R
,
Wu
H
,
Wang
J
,
Lian
CL
,
He
ZY
,
Zhang
WW
.
Lymph node status and outcomes for nasopharyngeal carcinoma according to histological subtypes: a SEER population-based retrospective analysis
.
Adv Ther
.
2019 Nov
36
11
3123
33
.
13.
Qu
W
,
Li
S
,
Zhang
M
,
Qiao
Q
.
Pattern and prognosis of distant metastases in nasopharyngeal carcinoma: a large-population retrospective analysis
.
Cancer Med
.
2020 Sep
9
17
6147
58
.
14.
Chen
J
,
Liu
T
,
Sun
Q
,
Hu
F
.
Clinical and prognostic analyses of 110 patients with N3 nasopharyngeal carcinoma
.
Medicine
.
2018 Dec
97
49
e13483
.
15.
Tian
YM
,
Huang
WZ
,
Lan
YH
,
Zhao
C
,
Bai
L
,
Han
F
.
Prognostic model and optimal treatment for patients with stage IVc nasopharyngeal carcinoma at diagnosis
.
Sci Rep
.
2019 Dec 17
9
1
19272
.
16.
Pan
CC
,
Lu
J
,
Yu
JR
,
Chen
P
,
Li
W
,
Huang
ZL
.
Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: a study of 1,027 cases and review of the literature
.
Exp Ther Med
.
2012 Aug
4
2
334
8
.
17.
Ren
Y
,
Qiu
H
,
Yuan
Y
,
Ye
J
,
Tian
Y
,
Wen
B
.
Evaluation of 7th edition of AJCC staging system for nasopharyngeal carcinoma
.
J Cancer
.
2017
;
8
(
9
):
1665
72
.
18.
Vaughan
TL
,
Shapiro
JA
,
Burt
RD
,
Swanson
GM
,
Berwick
M
,
Lynch
CF
.
Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type
.
Cancer Epidemiol Biomarkers Prev
.
1996 Aug
5
8
587
93
.
19.
Burt
RD
,
Vaughan
TL
,
McKnight
B
.
Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States
.
Int J Cancer
.
1992 Oct 21
52
4
549
56
.
20.
Huang
XD
,
Zhou
GQ
,
Lv
JW
,
Zhou
HQ
,
Zhong
CW
,
Wu
CF
.
Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a big-data, intelligence platform-based analysis
.
Radiother Oncol
.
2018 Nov
129
2
389
95
.
21.
Pan
XX
,
Liu
YJ
,
Yang
W
,
Chen
YF
,
Tang
WB
,
Li
CR
.
Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients
.
Laryngoscope
.
2020 Mar
130
3
E83
e88
.
22.
Farias
TP
,
Dias
FL
,
Lima
RA
,
Kligerman
J
,
de Sá
GM
,
Barbosa
MM
.
Prognostic factors and outcome for nasopharyngeal carcinoma
.
Arch Otolaryngol Head Neck Surg
.
2003 Jul
129
7
794
9
.
23.
Au
KH
,
Ngan
RKC
,
Ng
AWY
,
Poon
DMC
,
Ng
WT
,
Yuen
KT
.
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: a report of 3328 patients (HKNPCSG 1301 study)
.
Oral Oncol
.
2018 Feb
77
16
21
.
24.
Lin
YH
,
Huang
TL
,
Chien
CY
,
Chen
HC
,
Hsu
HC
,
Huang
EY
.
Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy
.
Radiat Oncol
.
2018 Mar 20
13
1
45
.
25.
Yao
JJ
,
Lin
L
,
Gao
TS
,
Zhang
WJ
,
Lawrence
WR
,
Ma
J
.
Development and validation of web-based nomograms to precisely predict survival outcomes of non-metastatic nasopharyngeal carcinoma in an endemic area
.
Cancer Res Treat
.
2021 Jul
53
3
657
70
.
26.
Jiang
Y
,
Qu
S
,
Pan
X
,
Huang
S
,
Zhu
X
.
Prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma
.
Sci Rep
.
2020 Jan 21
10
1
861
.
27.
Liu
YC
,
Wang
WY
,
Twu
CW
,
Jiang
RS
,
Liang
KL
,
Wu
CT
.
Prognostic impact of adjuvant chemotherapy in high-risk nasopharyngeal carcinoma patients
.
Oral Oncol
.
2017 Jan
64
15
21
.
28.
Pan
XB
,
Qu
S
,
Li
L
,
Chen
L
,
Liang
SX
,
Zhu
XD
.
Validation of stage N3 of the eighth edition AJCC staging system for nasopharyngeal carcinoma
.
Laryngoscope
.
2021
;
131
(
3
):
535
40
.
29.
Lin
S
,
Pan
J
,
Han
L
,
Guo
Q
,
Hu
C
,
Zong
J
.
Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin
.
Radiother Oncol
.
2014 Mar
110
3
385
9
.
30.
Sun
X
,
Su
S
,
Chen
C
,
Han
F
,
Zhao
C
,
Xiao
W
.
Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities
.
Radiother Oncol
.
2014 Mar
110
3
398
403
.
You do not currently have access to this content.